(Q28326662)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1835291%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

title

Acute bronchodilating effects of ipratropium bromide and theophylline in chronic obstructive pulmonary disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1835291%20AND%20SRC:MED&resulttype=core&format=json

chronic obstructive pulmonary disease

19 September 2019

main subject

1 reference

1 reference

E. R. Bleecker

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1835291

6 December 2022

E. J. Britt

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1835291

6 December 2022

language of work or name

English

0 references

publication date

1 October 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1835291%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

21 October 1991

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1835291

full work available at URL

6 December 2022

https://api.elsevier.com/content/article/PII:000293439190258Y?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90258-Y

https://api.elsevier.com/content/article/PII:000293439190258Y?httpAccept=text/plain

6 December 2022

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90258-Y

American Journal of Medicine

6 December 2022

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1835291%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

volume

91

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1835291%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

issue

4A

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1835291%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

page(s)

24S-27S

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1835291%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

2

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90258-Y

A randomized, controlled trial of theophylline in patients with severe chronic obstructive pulmonary disease

6 December 2022

3

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90258-Y

6 December 2022

Methylxanthines in 1989.

6

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90258-Y

Is theophylline obsolete?

6 December 2022

8

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90258-Y

6 December 2022

Ipratropium bromide

9

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90258-Y

A comparison of the effect of ipratropium and albuterol in the treatment of chronic obstructive airway disease

6 December 2022

11

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90258-Y

Ipratropium bromide and fenoterol by aerosolized solution

6 December 2022

14

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90258-Y

A comparative trial of ipratropium bromide (Atrovent), controlled release theophylline (Phyllocontin), and a combination of these in patients with reversible airflow obstruction

6 December 2022

16

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90258-Y

Combined therapy with ipratropium and theophylline in asthma

6 December 2022

17

1 reference

https://api.crossref.org/works/10.1016/0002-9343(91)90258-Y

6 December 2022

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1835291%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

1 reference